OncoTherapy Surges On TOPK Inhibitor Promise
This article was originally published in PharmAsia News
Executive Summary
Shares in OncoTherapy Sciences (OTS) surged in Tokyo on Oct. 24 after the Japanese bioventure published promising early findings with a novel anticancer small molecule, OTS964.